NCT06184828

Brief Summary

Our goal is to perform a pilot, single center study to evaluate the efficacy of whole blood (WB) in subjects with TBI, intracranial hemorrhage, and anemia compared to blood component therapy.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Aug 2024

Shorter than P25 for phase_3

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 7, 2023

Completed
21 days until next milestone

First Posted

Study publicly available on registry

December 28, 2023

Completed
7 months until next milestone

Study Start

First participant enrolled

August 1, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

April 2, 2024

Status Verified

April 1, 2024

Enrollment Period

1.2 years

First QC Date

December 7, 2023

Last Update Submit

April 1, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mortality and Morbidity

    The primary outcome for this study would be Glasgow Outcome Coma Scale score at discharge.

    Up to 30 days after hospital admission

Secondary Outcomes (1)

  • Improvement in Coagulopathy

    Up to 30 days after hospital admission

Study Arms (2)

Whole Blood Transfusion

EXPERIMENTAL

Transfusion of whole blood units

Biological: Whole blood transfusion

Blood Component Transfusion

ACTIVE COMPARATOR

Transfusion of blood components units

Biological: Blood components transfusion

Interventions

The transfusion of whole blood units

Whole Blood Transfusion

The transfusion of blood components units rather than whole blood

Blood Component Transfusion

Eligibility Criteria

Age15 Years - 120 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Age 15 years and older
  • Head CT with presence of intracranial bleeding
  • Required transfusion of whole blood (WB) or red blood cells (RBC)

You may not qualify if:

  • Patients with non-survivable injuries (expected to die within 24-hours of injury)
  • Fixed and dilated pupils
  • Patients requiring a massive transfusion protocol activation
  • Receipt of 2 units of WB or RBCs prior to enrollment
  • Known prisoners
  • Known pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (4)

  • Napolitano L. Cumulative risks of early red blood cell transfusion. J Trauma. 2006 Jun;60(6 Suppl):S26-34. doi: 10.1097/01.ta.0000199979.95789.17. No abstract available.

    PMID: 16763477BACKGROUND
  • Timmons SD. The life-saving properties of blood: mitigating cerebral insult after traumatic brain injury. Neurocrit Care. 2006;5(1):1-3. doi: 10.1385/NCC:5:1:1.

    PMID: 16960286BACKGROUND
  • Corwin HL, Carson JL. Blood transfusion--when is more really less? N Engl J Med. 2007 Apr 19;356(16):1667-9. doi: 10.1056/NEJMe078019. No abstract available.

    PMID: 17442910BACKGROUND
  • Reiles E, Van der Linden P. Transfusion trigger in critically ill patients: has the puzzle been completed? Crit Care. 2007;11(3):142. doi: 10.1186/cc5936.

    PMID: 17583592BACKGROUND

MeSH Terms

Conditions

Brain Injuries, Traumatic

Interventions

Exchange Transfusion, Whole Blood

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

Blood TransfusionBiological TherapyTherapeutics

Central Study Contacts

Laura H Nguyen

CONTACT

Samantha Underwood

CONTACT

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Pilot, single center, and a randomized 1:1 trial.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D., F.A.C.S., F.C.C.M.

Study Record Dates

First Submitted

December 7, 2023

First Posted

December 28, 2023

Study Start

August 1, 2024

Primary Completion

September 30, 2025

Study Completion

September 30, 2025

Last Updated

April 2, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share